Raj Malik, MD – G1 Therapeutics discusses G1 Therapeutics to present data showing myelopreservation benefits of Trilaciclib in patients with small cell lung cancer at the ASCO20 Virtual Scientific Program.
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-present-data-showing-myelopreservation-benefits
Advertisement